NCT01629212View on ClinicalTrials.gov

Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome

PHASE4UnknownINTERVENTIONAL
Timeline

Start Date

December 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

Tiropramide HCl 100mg

DRUG

Octylonium bromide 20mg

Trial Locations (1)

Unknown

RECRUITING

Han Yang University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY